Skip to main content
William Carroll, MD, Pediatric Hematology & Oncology, New York, NY, NYU Langone Hospitals

WilliamCarrollMD

Pediatric Hematology & Oncology New York, NY

Professor of Pediatrics, NYU School of Medicine

Dr. Carroll is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Carroll's full profile

Already have an account?

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1982 - 1983
  • Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1979 - 1982
  • University of Cincinnati Medical Center Inc.
    University of Cincinnati Medical Center Inc.Internship, Transitional Year, 1978 - 1979
  • University of California, Irvine, School of Medicine
    University of California, Irvine, School of MedicineClass of 1978
  • California State University, Chico
    California State University, ChicoB.A., Biological Sciences, Magna Cum Laude, 1969 - 1973

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1982 - Present
  • NY State Medical License
    NY State Medical License 2001 - 2024
  • FL State Medical License
    FL State Medical License 2020 - 2022
  • UT State Medical License
    UT State Medical License 1991 - 2002
  • OH State Medical License
    OH State Medical License 1979 - 1982
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Distinguished Alumnus, College of Natural Science California State University, Chico, 2011
  • Ben Abelson Memorial Visiting Professorship Washington University School of Medicine, 2010
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Loss of TBLXR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in childhood B-Lymphoblastic leukemia model  
    Jones CL, Bhatla T, Wang J, Bourgeois W, Bitterman D, Raetz E, Morrison D, Teachey D, Garabedian M, Carroll WL, J Biol Chem, 6/1/2014
  • A Prospective Study of Anxiety, Depression, and Behavioral Changes in the First Year after Diagnosis of Childhood Acute Lymphoblastic Leukemia  
    Myers RM, Balsamo L, Lu X, Devidas, M, Hunger SP, Carroll WL, Winick NJ, Maloney KW, and Kadan-Lottick NS, Cancer, 5/1/2014
  • Philadelphia chromosome negative very high risk acute lymphoblastic leukemia (ALL) in children and adolescents: results from children's oncology group (COG) study AALL...  
    Schultz KR, Devidas M, Bowman WP, Aledo A, Slayton WB, Sather H, Zheng HW, Davies SM, Gaynon PS, Trigg M, Rutledge R, Jorstad D, Carroll AJ, Heerema N, Winick N, Borow..., Leukemia, 4/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • The Genomic Landscape of Childhood Acute Lymphoblastic Leukemia
    William L. Carroll, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • FLT3 Inhibitor Correlative Laboratory Assays Impact Outcomes in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia (ALL) Patients Treated with Lestaurtinib: AALL0631...
    William L. Carroll, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Germline RUNX1 Variation and Predisposition to T-Cell Acute Lymphoblastic Leukemia in Children
    William L. Carroll, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Treating Childhood Leukemia in the Age of Genomics. 
    Mount Sinai Medical Center, New York, NY - 2/13/2014
  • The Evolutionary Forces That Drive Treatment Failure In Childhood Cancer – Lessons Learned from Treating Acute Lymphoblastic Leukemia. 
    Hershey, PA - 10/25/2013
  • The Genetic and Molecular Evolution of Relapsed ALL-Clues to Drug Resistance Pathways. 
    Washington, DC - 9/16/2013
  • Join now to see all

Press Mentions

  • p73α Isoforms Drive Opposite Transcriptional and Post-Transcriptional Regulation of MYCN Expression in Neuroblastoma Cells
    p73α Isoforms Drive Opposite Transcriptional and Post-Transcriptional Regulation of MYCN Expression in Neuroblastoma CellsJune 25th, 2020

Hospital Affiliations